Elite in Hepatitis B

Hong J. You

301 Middle Yanchang Road, 
Shanghai, CN 
Elite in Hepatitis B
301 Middle Yanchang Road, 
Shanghai, CN 
OverviewLocationsClinical Research

Overview

Hong You practices in Shanghai, China. Ms. You is rated as an Elite expert by MediFind in the treatment of Hepatitis B. Her top areas of expertise are Cirrhosis, Hepatitis B, Hepatitis, Liver Transplant, and Vertebroplasty.

Her clinical research consists of co-authoring 352 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 74 articles and participated in 4 clinical trials in the study of Hepatitis B.

Gender
Female

Locations

301 Middle Yanchang Road, Shanghai, 200072, China
Other Locations
Middle Renmin Road 139, Changsha, 410011, China
No. 1 Shizishan Street, Wuhan, 430070, China
95 Yong An Road, Beijing, 100050, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

Effect of Entecavir Treatment on Regression and Long-term Disease Outcome in Patients With HBV-induced Liver Fibrosis and Cirrhosis (Regress Extension Study)
Effect of Entecavir Treatment on Regression and Long-term Disease Outcome in Patients With HBV-induced Liver Fibrosis and Cirrhosis (Regress Extension Study)
Enrollment Status: Active_not_recruiting
Publish Date: April 28, 2021
Intervention Type: Drug
Study Drug: Entecavir
Study Phase: Phase 4
Optimized Treatment and Regression of HBV-induced Liver Fibrosis
Optimized Treatment and Regression of HBV-induced Liver Fibrosis
Enrollment Status: Completed
Publish Date: July 27, 2018
Intervention Type: Drug
Study Phase: Phase 4
Optimized Treatment and Regression of HBV-induced Early Cirrhosis
Optimized Treatment and Regression of HBV-induced Early Cirrhosis
Enrollment Status: Completed
Publish Date: July 27, 2018
Intervention Type: Drug
Study Phase: Phase 4
Optimized Treatment and Regression of HBV-induced Compensated Liver Cirrhosis
Optimized Treatment and Regression of HBV-induced Compensated Liver Cirrhosis
Enrollment Status: Completed
Publish Date: July 27, 2018
Intervention Type: Drug
Study Phase: Phase 4
View 3 Less Clinical Trials

352 Total Publications

Analysis of the efficacy of orlistat combined with pioglitazone and metformin in the treatment of obese patients with type 2 diabetes mellitus
Analysis of the efficacy of orlistat combined with pioglitazone and metformin in the treatment of obese patients with type 2 diabetes mellitus
Journal: Zhonghua yi xue za zhi
Published: October 13, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. You's expertise for a condition
ConditionClose
View All 11 Advanced Conditions
View All 21 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile